Paid Clinical Trials in Portland, ME
As of July 2026, 77 paid clinical trials are recruiting in Portland, Maine. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Portland offers studies at sites including MaineHealth Maine Medical Center - Portland for conditions such as Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia, Myelodysplasia-Related. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Portland
Trials by drug in Portland
Filter results
Newly added in Portland
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
69 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Study of DONQ52 in Active Celiac Disease
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
The THOR IDE Study
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Top Research Study Locations in Portland
Researchers run research studies in Portland, ME at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center - Portland | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 23 |
| Maine Medical Center | Atrial Fibrillation, Heart Failure, ADHD | 20 |
| MaineHealth | Aging, Alzheimer Disease, Aneurysmal Subarachnoid Hemorrhage (aSAH) | 4 |
| Maine Medical Partners Pediatric Specialty Care | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| Maine Eye Center | Geographic Atrophy, Macular Degeneration, Neovascular Age-related Macular Degeneration | 3 |
| Maine Health | Cancer, Irritable Bowel Syndrome With Constipation (IBS-C), Myocarditis Acute | 2 |
| MaineHealth Maine Medical Center | Burn (Disorder), Burn Degree Second, Burns Degree Third | 2 |
| Portland Gastroenterology Center | Celiac Disease, Crohn's Disease, Ulcerative Colitis | 2 |
| Maine Eye Center - Marginal Way Campus | AMD, CNV, Wet Age-related Macular Degeneration | 2 |
| Eyecare Medical Group | Dry Age Related Macular Degeneration, Epiretinal Membrane, IS/OS (Ellipsoid Zone) Disruption | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Maine Health - Maine Medical Center | Homocystinuria | 1 |
| Maine Health Pediatric Specialty Care | Homocystinuria | 1 |
| Maine Health Research Institute | Type 1 Diabetes | 1 |
| Maine Medical Center - Bramhall Campus | Hepatitis | 1 |
| Maine Medical Center - Division of Pulmonary and Critical Care Medicine | Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI), Pancreatic Diseases | 1 |
| Maine Medical Center-Bramhall Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Centre | Community-acquired Pneumonia | 1 |
| Maine Medical Partners | Colitis, Ulcerative | 1 |
| MaineHealth Maine Medical Center Portland | Interprofessional Education, Neonatal Resuscitation, Rural Health | 1 |
| MaineHealth Pediatric Specialty Care | Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI) | 1 |
| Northern Light Breast Care | Breast Cancer | 1 |
| Ovation.io | Cancer, Other Disease | 1 |
| Portland Gastroenterology Center - Portland - Congress Street | Crohn's Disease, Ulcerative Colitis | 1 |
| The Vascular Care Group | PAD, Peripheral Artery Calcification, Peripheral Artery Disease | 1 |
Active & Upcoming Studies in Portland (2026)
Recruiting trials in Portland grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (25 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · Phase 3 · NRG Oncology
Cardiovascular (8 active studies)
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure · Abbott Medical Devices
- CTSN Embolic Protection Trial · Icahn School of Medicine at Mount Sinai
Eye & vision (6 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
Neurology & pain (3 active studies)
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders · University of Michigan
- CTSN Embolic Protection Trial · Icahn School of Medicine at Mount Sinai
Diabetes & metabolic (2 active studies)
Pediatric (2 active studies)
- Comparative Study of Simulation Technologies for Use in Neonatal Resuscitation Training for Rural Hospitals · MaineHealth
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
Common conditions studied in Portland
- Acute Myeloid Leukemia (6 active studies)
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (2 active studies)
- Acute Myeloid Leukemia, Myelodysplasia-Related (2 active studies)
- Atrial Fibrillation (2 active studies)
- Cancer (2 active studies)
Leading research sponsors in Portland
- National Cancer Institute (NCI)
- NRG Oncology
- AbbVie
- Alliance for Clinical Trials in Oncology
- Genzyme, a Sanofi Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Portland?
There are approximately 77 recruiting clinical trials in Portland, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Portland pay participants?
Most recruiting trials in Portland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Portland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Portland?
The most common conditions under active study in Portland include Acute Myeloid Leukemia (6), Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2), Acute Myeloid Leukemia Post Cytotoxic Therapy (2), Acute Myeloid Leukemia, Myelodysplasia-Related (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Portland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Portland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Portland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Portland?
Recruiting research sites in Portland include MaineHealth Maine Medical Center - Portland, Maine Medical Center, MaineHealth, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Portland right now?
The largest active categories in Portland are Cancer & tumors (25), Cardiovascular (8), Eye & vision (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.